ARTICLE | Company News
Arena, Ferring Group deal
June 3, 2002 7:00 AM UTC
ARNA will use its Constitutively Activated Receptor Technology (CART) to develop for Ferring's Ferring Pharmaceuticals Inc. subsidiary an activated version of a GPCR target involved in reproductive bi...